Angela Anigbogu

Title: Angela Anigbogu: Innovator in Progestin-Only Contraception

Introduction

Angela Anigbogu is a notable inventor based in Salt Lake City, Utah. She has made significant contributions to the field of contraception, particularly through her innovative formulations and methods. With a total of two patents to her name, her work focuses on minimizing adverse side effects associated with progestin-only contraception.

Latest Patents

Angela's latest patents include formulations and methods for providing progestin-only contraception while minimizing adverse side effects. These patents describe methods that can include transdermally administering a formulation containing a contraceptively effective amount of a single progestin as the sole active hormonal agent. This approach aims to reduce common side effects, such as breakthrough bleeding, that are typically associated with progestin-only contraception.

Career Highlights

Throughout her career, Angela has worked with prominent companies in the pharmaceutical industry, including Allergan Sales, Inc. and Watson Laboratories Inc. Her experience in these organizations has contributed to her expertise in developing effective contraceptive solutions.

Collaborations

Angela has collaborated with notable professionals in her field, including Charles D. Ebert and Gary Hoel. These collaborations have likely enhanced her research and development efforts in contraception.

Conclusion

Angela Anigbogu stands out as an innovative inventor in the realm of progestin-only contraception. Her patents reflect her commitment to improving women's health by minimizing side effects associated with contraceptive methods.